Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
02:06:19 EDT Tue 15 Sep 2026
Enter Symbol
or Name
USA
CA



Forgot password?
Trouble logging in?
Login ID:
Password:
Save

Q:ANIX - ANIXA BIOSCIENCES INC - https://www.anixa.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
ANIX - Q0.62.73·3.183.02.80+0.041.4376.49421,3892.79  2.88  2.765.455  2.3219:30:00Sep 0915 min RT 2¢

Recent Trades - Last 10 of 1389
Time ETExPriceChangeVolume
19:30:00Q2.800.041
19:30:00Q2.800.041
19:30:00Q2.800.041
19:30:00Q2.800.041
17:38:21Q2.810.0540
17:32:21Q2.890.131
17:32:21Q2.89970.13971
17:02:15Q2.840.082
17:02:15Q2.840.082
16:10:04Q2.800.041

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-09-09 08:35U:ANIXNews ReleaseAnixa Biosciences Interview Highlighting Breast Cancer Vaccine to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
2026-09-03 08:00U:ANIXNews ReleaseAnixa Biosciences to Present at the Nasdaq & LD Micro Inaugural SF Summit on September 9, 2026
2026-08-24 08:55U:ANIXNews ReleaseAnixa Biosciences to Present at the 2026 Cantor Fitzgerald Global Healthcare Conference Highlighting its Breast Cancer Vaccine and Ovarian Cancer CAR-T Therapy
2026-08-18 08:45U:ANIXNews ReleaseAnixa Biosciences to Present at the H.C. Wainwright 28th Annual Global Investment Conference
2026-07-06 08:30U:ANIXNews ReleaseAnixa Biosciences and Moffitt Cancer Center Advance Ovarian Cancer CAR-T Clinical Trial to Highest Dose Level to Date
2026-06-29 08:45U:ANIXNews ReleaseAnixa Biosciences Granted First Korean Patent for its Breast Cancer Vaccine, Extending Global Protection Through 2040
2026-06-26 09:10U:ANIXNews ReleaseAnixa Biosciences Reports Positive Data from Completed Breast Cancer Vaccine Phase 1 Trial and Positive Survival Observations from Ongoing CAR-T Phase 1 Trial at New York Academy of Sciences' Frontiers in Cancer Immunotherapy Symposium
2026-06-11 09:05U:ANIXNews ReleaseAnixa Biosciences Announces Presentations of Two Clinical-Stage Immunotherapy Programs at New York Academy of Sciences' Frontiers in Cancer Immunotherapy Symposium
2026-06-01 09:00U:ANIXNews ReleaseAnixa Biosciences Strengthens International Patent Protection for Ovarian Cancer Vaccine Technology with Canadian Notice of Allowance
2026-05-11 11:48U:ANIXNews Release/C O R R E C T I O N -- Anixa Biosciences, Inc./
2026-05-11 08:55U:ANIXNews ReleaseAnixa Biosciences Reports Updated Positive Survival Observations from Ongoing Phase 1 Trial of Lira-cel Ovarian Cancer CAR-T Therapy
2026-05-01 09:15U:ANIXNews ReleaseAnixa Biosciences Interview to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
2026-04-29 09:10U:ANIXNews ReleaseAnixa Biosciences Announces Issuance of Mexican Patent Covering Breast Cancer Vaccine Technology
2026-04-22 08:45U:ANIXNews ReleaseAnixa Biosciences Announces Presentation of its Ovarian Cancer CAR-T Therapy at the International Society for Cell & Gene Therapy 2026 Annual Meeting
2026-04-09 09:05U:ANIXNews ReleaseAnixa Biosciences to Participate in RedChip's Biotech Resurgence: Platforms and Pipelines of Today's Innovators Conference on April 16, 2026
2026-04-07 08:55U:ANIXNews ReleaseAnixa Biosciences to Participate in Water Tower Research Insights Conference on April 14, 2026
2026-04-06 09:10U:ANIXNews ReleaseAnixa Biosciences CEO Featured on Smart Money Circle Interview Highlighting Advances in Cancer Immunotherapy Programs
2026-04-01 08:50U:ANIXNews ReleaseAnixa Biosciences Advances Breast Cancer Vaccine Toward Phase 2 After Positive Phase 1 Results; Cytovance Selected for cGMP Manufacturing
2026-03-30 09:05U:ANIXNews ReleaseAnixa Biosciences Announces Presentation of its Ovarian Cancer CAR-T Therapy Clinical Trial at the Society of Gynecologic Oncology Annual Meeting on Women's Cancer
2026-03-12 10:38U:ANIXNews ReleaseAnixa Biosciences Featured on Water Tower Research Healthcare Happenings Podcast